Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?

Published:2024-08-30 Issue: Volume: Page:1-10
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Simadibrata Daniel Martin¹²³^ORCID,Lesmana Elvira²³,Lee Yeong Yeh⁴⁵^ORCID

Affiliation:

1. Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA

2. Medicine, Universitas Indonesia, Jakarta, Indonesia

3. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

4. School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia

5. GI Function and Motility Unit, Hospital USM, Kota Bharu, Malaysia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2024.2393868

Reference80 articles.

1. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis

2. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

3. Drugs for improving esophageal mucosa defense: where are we now and where are we going?

4. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A meta-analysis

5. Proton Pump Inhibitor–Refractory Gastroesophageal Reflux Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP